{"nct_id":"NCT03142334","title":"Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2017-06-09","start_date_type":"ACTUAL","primary_completion_date":"2020-12-14","primary_completion_date_type":"ACTUAL","completion_date":"2025-12-28","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}